polyethylene glycol OTC
Selected indexed studies
- OTC polyethylene glycol 3350 and pharmacists' role in managing constipation. (J Am Pharm Assoc (2003), 2012) [PMID:22618979]
- History of gene therapy. (Gene, 2013) [PMID:23618815]
- Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. (Am J Gastroenterol, 2021) [PMID:33767108]
_Worker-drafted node — pending editorial review._
Connections
polyethylene glycol OTC is a side effect of
Sources
- Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. (2021) pubmed
- OTC polyethylene glycol 3350 and pharmacists' role in managing constipation. (2012) pubmed
- History of gene therapy. (2013) pubmed
- Novel vectors and approaches for gene therapy in liver diseases. (2021) pubmed
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives. (2022) pubmed
- OTC product: MiraLAX. (2007) pubmed
- Evidence-based treatment recommendations for OTC management of chronic constipation. (2022) pubmed
- The therapeutic potential of pegylated arginase I treatment in glioblastoma. (2025) pubmed
- Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. (2021) pubmed
- A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum. (2019) pubmed